McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership

by McKesson Ventures | Aug 28, 2024 | Press Releases

On Wednesday, at-home oncology care provider Reimagine Care announced that it was forming a strategic partnership with the Texas-based not-for-profit Memorial Hermann Health System to further increase the quality of provider care for cancer patients, with a specific...

Reimagine Care Welcomes Dan Nardi, Healthcare Industry Leader, as New CEO

by McKesson Ventures | Jul 10, 2023 | Press Releases

Reimagine Care has announced that Dan Nardi will serve as its new Chief Executive Officer, effective July 10, 2023. Nardi replaces co-founder Dr. Aaron Gerber as CEO. Previously, Nardi served as Carrum Health’s Chief Operating Officer and Livongo’s Vice President of...

Recent Posts

  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
  • Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration
  • HarmonyCares Announces 2023 Results for its High Needs REACH ACO
  • Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration

HarmonyCares Announces 2023 Results for its High Needs REACH ACO

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow